XML 34 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Disaggregation of Sales, Geographic Sales and Product Sales
6 Months Ended
Jul. 03, 2020
Segment Reporting [Abstract]  
Disaggregation of Sales, Geographic Sales and Product Sales

Note 14 — Disaggregation of Sales, Geographic Sales and Product Sales

In the following tables, sales are disaggregated by category, sales by geographic market and sales by product data.  The following breaks down sales into the following categories (in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2020

 

 

June 28, 2019

 

 

July 3, 2020

 

 

June 28, 2019

 

Non-consignment sales

 

$

23,446

 

 

$

35,556

 

 

$

53,846

 

 

$

63,822

 

Consignment sales

 

 

11,748

 

 

 

4,108

 

 

 

16,535

 

 

 

8,425

 

Total net sales

 

$

35,194

 

 

$

39,664

 

 

$

70,381

 

 

$

72,247

 

 

The Company markets and sells its products in over 75 countries and conducts its manufacturing in the United States.  Other than China and Japan, the Company does not conduct business in any country in which its sales exceed 10% of worldwide consolidated net sales. Sales are attributed to countries based on location of customers. The composition of the Company’s net sales to unaffiliated customers was as follows (in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2020

 

 

June 28, 2019

 

 

July 3, 2020

 

 

June 28, 2019

 

Domestic

 

$

882

 

 

$

2,114

 

 

$

2,621

 

 

$

4,066

 

Foreign:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

China

 

 

18,603

 

 

 

19,394

 

 

 

30,318

 

 

 

31,165

 

Japan

 

 

7,463

 

 

 

6,275

 

 

 

15,765

 

 

 

11,794

 

Other(1)

 

 

8,246

 

 

 

11,881

 

 

 

21,677

 

 

 

25,222

 

Total foreign sales

 

 

34,312

 

 

 

37,550

 

 

 

67,760

 

 

 

68,181

 

Total net sales

 

$

35,194

 

 

$

39,664

 

 

$

70,381

 

 

$

72,247

 

 

(1)

No other location individually exceeds 10% of the total sales.

100% of the Company’s sales are generated from the ophthalmic surgical product segment and the chief operating decision maker makes operating decisions and allocates resources based upon the consolidated operating results, and therefore the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are implantable Collamer lenses (“ICLs”) used in refractive surgery and intraocular lenses (“IOLs”) used in cataract surgery.  The composition of the Company’s net sales by product line was as follows (in thousands):

 

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

July 3, 2020

 

 

June 28, 2019

 

 

July 3, 2020

 

 

June 28, 2019

 

ICLs

 

$

30,728

 

 

$

34,432

 

 

$

60,068

 

 

$

62,218

 

Other product sales

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IOLs

 

 

2,561

 

 

 

3,874

 

 

 

6,555

 

 

 

7,891

 

Other surgical products

 

 

1,905

 

 

 

1,358

 

 

 

3,758

 

 

 

2,138

 

Total other product sales

 

 

4,466

 

 

 

5,232

 

 

 

10,313

 

 

 

10,029

 

Total net sales

 

$

35,194

 

 

$

39,664

 

 

$

70,381

 

 

$

72,247

 

 

One customer, the Company’s distributor in China, accounted for 53% and 43% of net sales for the three and six months ended July 3, 2020, respectively, and the same customer, accounted for 49% and 43% of net sales for the three and six months ended June 28, 2019, respectively.  As of July 3, 2020 and January 3, 2020, respectively, one customer, the Company’s distributor in China, accounted for 57% and 43% of consolidated trade receivables.